The text discusses Myeloid Derived Suppressor Cells (MDSC), a group of myeloid cells known for their ability to suppress T-cell responses in various conditions, particularly in cancer. The study aimed to identify specific subsets of MDSC responsible for immune suppression in tumor-bearing mice. Using different tumor models, the study found variability in MDSC expansion, with granulocytic MDSC being the predominant subset expanded in most models. Both granulocytic and monocytic MDSC subsets exhibited different mechanisms of T-cell suppression, with granulocytic MDSC showing higher ROS levels and monocytic MDSC showing higher NO levels. The study also investigated the role of surface molecules like PD-L1, PD-L2, CD80, M-CSF receptor, and IL-4 receptor Î± in MDSC function, finding no preferential accumulation of cells expressing these molecules in tumor models. The results suggest that MDSC-mediated immune suppression in cancer may not be attributed to specific subsets but rather to the entire population of these cells.